Participants 369 418 5
n subjects with symptomatic moderate to severe CO
Participants 510 716 7
. Subjects 40 years or older with cigarette smoking history ≥10 pack-years and with the diagnosis of COPD and post-bronchodilator FEV(1) ≥40 to ≤ 80% of predicted normal and FEV(1)/FVC of ≤0.70 were
Participants 1599 1634 4
on of FSC to subjects with COPD tre
